Target Health Resources

CRO

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials

February 15, 2017

,
CRO
|
Article

The regulatory push to the paperless clinical trial has occurred despite a pharmaceutical industry that has been risk-averse in adopting modern-day technology tools that could support clinical trials.

The Electronic Informed Consent Has Arrived

February 15, 2017

,
CRO
|
Article

The following are points to consider when designing and using an electronic informed consent form (eICF)

Disruptive Innovations 2016

September 20, 2016

,
CRO
|
Lecture

Dr. Jules Mitchel at Disruptive Innovations in Boston, September 20, 2016

Target Health is Finalist for Clinical Research Sites' Eagle Award

August 13, 2015

,
CRO
|
News

The Society for Clinical Research Sites (SCRS), the trade organization representing over 2,600 global clinical research sites in 42 countries, announces today the finalists for the 2015 SCRS Eagle Award.

2015 PharmaVOICE 100 Interview with Jules Mitchel Ph.D.

August 10, 2015

,
CRO
|
News

Dr. Jules Mitchel shares what it's like being an inspiration to the industry, how he inspires his team and peers, who has inspired him, and the innovations he is seeing in the industry.

Interview: Dr. Jules Mitchel - Paperless Clinical Trials

July 1, 2015

,
CRO
|
News

PharmaVOICE interview with Dr. Jules Mitchel, the Commander in Chief of Target Health, Inc.

Dignitana AB Collaborates with Target Health Inc.

March 19, 2015

,
CRO
|
News

Dignitana AB announced that the company has submitted for review an application to the US Food and Drug Administration (FDA) Center for Devices and Radiologic Health for approval of the DigniCap™ System. Dignitana engaged the Clinical Research Organization (CRO) Target Health Inc., with offices in New York, in 2011, and Dignitana has been working in close collaboration with Target Health to interact with FDA, conduct the pivotal clinical trial and prepare the FDA application.

Working with FDA

October 29, 2014

,
CRO
|
Presentation

Working with FDA: How creative one can be when working with FDA to optimize the drug and device development process.

Experience from Phase 3 Study Using Risk- Based Monitoring and eSource Methodologies

December 1, 2013

,
CRO
|
Presentation

How to efficiently and effectively balance central monitoring with on-site monitoring using Risk Based Monitoring (RMB) and eSource methodologies

Lessons Learned From Direct Data Entry

July 4, 2012

,
CRO
|
Article

Lessons Learned From a Direct Data Entry Phase 2 Clinical Trial Under a US Investigational New Drug Application

A CTTI Survey of Current Monitoring Practices

May 17, 2010

,
CRO
|
Presentation

Slides from Society for Clinical Trials, The goal of this CTTI-sponsored project was to describe current clinical monitoring methods for a range of clinical trial types, and to explore the rationale for the use of those methods.

A CTTI Survey of Current Monitoring Practices

May 1, 2010

,
CRO
|
Poster

The goal of this CTTI-sponsored project was to describe current clinical monitoring methods for a range of clinical trial types, and to explore the rationale for the use of those methods.